Collaborative research in childhood cancer survivorship: The current landscape

Journal of Clinical Oncology

Volumn 33, Issue 27, 2015, Pages 3055-3064

  Bhatia, Smita ^a   Armenian, Saro H ^a   Armstrong, Gregory T ^b   Van Dulmen Den Broeder, Eline ^c   Hawkins, Michael M ^e   Kremer, Leontien C M ^d   Kuehni, Claudia E ^f   Olsen, Jørgen H ^g   Robison, Leslie L ^b   Hudson, Melissa M ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY OF BERN   (Switzerland)

^g DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADVERSE OUTCOME; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CANCER SURVIVOR; CANCER THERAPY; CHILDHOOD CANCER; CLINICAL ASSESSMENT; FOLLOW UP; GENETIC SUSCEPTIBILITY; HODGKIN DISEASE; HUMAN; MORBIDITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; ADOLESCENT; CHILD; COOPERATION; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; HEALTH STATUS; INTERDISCIPLINARY COMMUNICATION; INTERNATIONAL COOPERATION; MASS COMMUNICATION; MORTALITY; NEOPLASMS; ONCOLOGY; ONSET AGE; PEDIATRICS; RISK ASSESSMENT; RISK FACTOR; STANDARDS; SURVIVOR; TIME; TREATMENT OUTCOME; TRENDS; YOUNG ADULT;

ADOLESCENT; AGE OF ONSET; CHILD; COOPERATIVE BEHAVIOR; COST-BENEFIT ANALYSIS; DIFFUSION OF INNOVATION; HEALTH CARE COSTS; HEALTH STATUS; HUMANS; INTERDISCIPLINARY COMMUNICATION; INTERNATIONAL COOPERATION; MEDICAL ONCOLOGY; NEOPLASMS; PEDIATRICS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84942250927     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.59.8052     Document Type: Article

References (75)

1. American Cancer Society: Global Cancer Facts and Figures (ed 2). Atlanta, GA, American Cancer Society, 2011
2. Adamson PC: The Children's Oncology Group's 2013 five year blueprint for research. Pediatr Blood Cancer 60:955-956, 2013
3. Armenian SH, Landier W, Hudson MM, et al: Children's Oncology Group's 2013 blueprint for research: Survivorship and outcomes. Pediatr Blood Cancer 60:1063-1068, 2013
4. Tebbi CK, London WB, Friedman D, et al: Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. J Clin Oncol 25:493-500, 2007
5. Vrooman LM, Neuberg DS, Stevenson KE, et al: The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium. Eur J Cancer 47:1373-1379, 2011
6. Levine J, Canada A, Stern CJ: Fertility preservation in adolescents and young adults with cancer. J Clin Oncol 28:4831-4841, 2010
7. Oeffinger KC, Mertens AC, Sklar CA, et al: Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572-1582, 2006
8. von der Weid N, Beck D: Late sequelae in a group of children and adolescents treated for cancer between 1981 and 1986 in Switzerland. Schweizerische medizinische Wochenschrift 123:1293-1299, 1993
9. von der Weid N, Mosimann I, Hirt A, et al: Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: Age-and sex-related differences. Eur J Cancer 39:359-365, 2003
10. Armstrong GT, Kawashima T, Leisenring W, et al: Aging and risk of severe, disabling, lifethreatening, and fatal events in the childhood cancer survivor study. J Clin Oncol 32:1218-1227, 2014
11. Geenen MM, Cardous-Ubbink MC, Kremer LC, et al: Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297:2705-2715, 2007
12. Bhatia S, Sklar C: Second cancers in survivors of childhood cancer. Nat Rev Cancer 2:124-132, 2002
13. Olsen JH, Moller T, Anderson H, et al: Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 101:806-813, 2009
14. Reulen RC, Frobisher C, Winter DL, et al: Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 305: 2311-2319, 2011
15. Friedman DL, Whitton J, Leisenring W, et al: Subsequent neoplasms in 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 102:1083-1095, 2010
16. Cardous-Ubbink MC, Heinen RC, Bakker PJ, et al: Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer 43:351-362, 2007
17. Armstrong GT, Liu W, Leisenring W, et al: Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: A report from the childhood cancer survivor study. J Clin Oncol 29:3056-3064, 2011
18. Inskip PD, Robison LL, Stovall M, et al: Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol 27:3901-3907, 2009
19. Neglia JP, Robison LL, Stovall M, et al: New primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98:1528-1537, 2006
20. Sigurdson AJ, Ronckers CM, Mertens AC, et al: Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study. Lancet 365:2014-2023, 2005
21. Watt TC, Inskip PD, Stratton K, et al: Radiation-related risk of basal cell carcinoma: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 104:1240-1250, 2012
22. Moskowitz CS, Chou JF, Wolden SL, et al: Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol 32:2217-2223, 2014
23. Castellino SM, Geiger AM, Mertens AC, et al: Morbidity and mortality in long-term survivors of Hodgkin lymphoma: A report from the Childhood Cancer Survivor Study. Blood 117:1806-1816, 2011
24. Bhatia S, Sather HN, Pabustan O, et al: Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 99:4257-4264, 2002
25. Mulrooney DA, Yeazel MW, Kawashima T, et al: Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 339:b4606, 2009
26. Bowers DC, Liu Y, Leisenring W, et al: Lateoccurring stroke among long-term survivors of childhood leukemia and brain tumors: A report from the Childhood Cancer Survivor Study. J Clin Oncol 24: 5277-5282, 2006
27. Hudson MM, Ness KK, Gurney JG, et al: Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309: 2371-2381, 2013
28. van der Pal HJ, van Dalen EC, van Delden E, et al: High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol 30:1429-1437, 2012
29. Meacham LR, Chow EJ, Ness KK, et al: Cardiovascular risk factors in adult survivors of pediatric cancer: A report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev 19:170-181, 2010
30. Oeffinger KC, Adams-Huet B, Victor RG, et al: Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 27:3698-3704, 2009
31. Nottage KA, Ness KK, Li C, et al: Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia: From the St Jude Lifetime Cohort. Br J Haematol 165:364-374, 2014
32. van Waas M, Neggers SJ, Pieters R, et al: Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer. Ann Oncol 21:1121-1126, 2010
33. Meacham LR, Sklar CA, Li S, et al: Diabetes mellitus in long-term survivors of childhood cancer: Increased risk associated with radiation therapy-A report for the Childhood Cancer Survivor Study. Arch Intern Med 169:1381-1388, 2009
34. Armstrong GT, Oeffinger KC, Chen Y, et al: Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol 31:3673-3680, 2013
35. Smith SC Jr, Collins A, Ferrari R, et al: Our time: A call to save preventable death from cardiovascular disease (heart disease and stroke). J Am Coll Cardiol 60:2343-2348, 2012
36. Greenland P, Alpert JS, Beller GA, et al: 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 122:e584-e636, 2010
37. Smith WA, Li C, Nottage KA, et al: Lifestyle and metabolic syndrome in adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study. Cancer 120:2742-2750, 2014
38. Ness KK, Jones KE, Smith WA, et al: Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: Results from the St Jude Lifetime Cohort Study. Arch Phys Med Rehabil 94:1451-1457, 2013
39. Ness KK, Krull KR, Jones KE, et al: Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: A report from the St Jude Lifetime cohort study. J Clin Oncol 31:4496-4503, 2013
40. de Fine Licht F, Winther JF, Gudmundsdottir T, et al: Hospital contacts for endocrine disorders in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): A population-based cohort study. Lancet 383:1981-1989, 2014
41. Holmqvist AS, Olsen JH, Andersen KK, et al: Adult life after childhood cancer in Scandinavia: Diabetes mellitus following treatment for cancer in childhood. Eur J Cancer 50:1169-1175, 2014
42. Green DM, Liu W, Kutteh WH, et al: Cumulative alkylating agent exposure and sperm parameters among adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study. Lancet Oncol 15:1215-1223, 2014
43. Green DM, Zhu L, Zhang N, et al: Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: A report from the St Jude lifetime cohort study. J Clin Oncol 31:1324-1328, 2013
44. Gurney JG, Kaste SC, Liu W, et al: Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: Results from the St Jude Lifetime Cohort Study. Pediatr Blood Cancer 61:1270-1276, 2014
45. Chemaitilly W, Li Z, Huang S, et al: Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: A report from the St Jude Lifetime Cohort Study. J Clin Oncol 33:492-500, 2015
46. Mertens AC, Liu Q, Neglia JP, et al: Causespecific late mortality among 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 100:1368-1379, 2008
47. Reulen RC, Winter DL, Frobisher C, et al: Long-term cause-specific mortality among survivors of childhood cancer. JAMA 304:172-179, 2010
48. Garwicz S, Anderson H, Olsen JH, et al: Late and very late mortality in 5-year survivors of childhood cancer: Changing pattern over four decadesexperiences from the Nordic countries. Int J Cancer 131:1659-1666, 2012
49. Cardous-Ubbink MC, Heinen RC, Langeveld NE, et al: Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer 42:563-573, 2004
50. Armstrong GT, Liu Q, Yasui Y, et al: Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study. J Clin Oncol 27:2328-2338, 2009
51. Armenian SH, Bhatia S: Chronic health conditions in childhood cancer survivors: Is it all treatment-related-Or do genetics play a role? J Gen Intern Med 24 suppl 2:S395-S400, 2009
52. Blanco JG, Sun CL, Landier W, et al: Anthracycline-related cardiomyopathy after childhood cancer: Role of polymorphisms in carbonyl reductase genes-A report from the Children's Oncology Group. J Clin Oncol 30:1415-1421, 2012
53. Wang X, Liu W, Sun CL, et al: Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: A report from the Children's Oncology Group. J Clin Oncol 32:647-653, 2014
54. Visscher H, Ross CJ, Rassekh SR, et al: Pharmacogenomic prediction of anthracyclineinduced cardiotoxicity in children. J Clin Oncol 30: 1422-1428, 2012
55. Hewitt M WS, Simone JV (eds): Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington, DC, National Academies Press, 2003
56. Nathan PC, Ness KK, Mahoney MC, et al: Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Ann Intern Med 153:442-451, 2010
57. Rebholz CE, von der Weid NX, Michel G, et al: Follow-up care amongst long-term childhood cancer survivors: A report from the Swiss Childhood Cancer Survivor Study. Eur J Cancer 47:221-229, 2011
58. Henderson TO, Hlubocky FJ, Wroblewski KE, et al: Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: A mailed survey of pediatric oncologists. J Clin Oncol 28:878-883, 2010
59. Nathan PC, Daugherty CK, Wroblewski KE, et al: Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. J Cancer Surviv 7:275-282, 2013
60. Suh E, Daugherty CK, Wroblewski K, et al: General internists' preferences and knowledge about the care of adult survivors of childhood cancer: A cross-sectional survey. Ann Intern Med 160: 11-17, 2014
61. Scottish Intercollegiate Guidelines Network: Long-Term Follow-Up of Survivors of Childhood Cancer: A National Clinical Guideline. Edinburgh, Scotland, Scottish Intercollegiate Guidelines Network, 2004
62. Dutch Childhood Oncology Group: Richtlijn follow-up na kinderkanker meer dan 5 jaar na diagnose. https://www.skion.nl/workspace/uploads/richtlijn-followup-na-kinderkanker-deel-1.pdf
63. United Kingdom Children's Cancer Study Group Late Effects Group: Therapy-based long-term follow-up. http://www.cclg.org.uk/dynamic-files/LTFU-full.pdf
64. Children's Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers: version 4.0, 2014. http://www.survivorshipguidelines.org
65. Landier W, Bhatia S, Eshelman DA, et al: Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group long-term follow-up guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22:4979-4990, 2004
66. Landier W, Armenian SH, Lee J, et al: Yield and utility of screening for long-term complications using the Children's Oncology Group long-term follow-up guidelines. J Clin Oncol 30:4401-4408, 2012
67. Wong FL, Bhatia S, Landier W, et al: Costeffectiveness of the Children's Oncology Group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure. Ann Intern Med 160:672-683, 2014
68. Kremer LC, Mulder RL, Oeffinger KC, et al: A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer 60:543-549, 2013
69. Brouwers MC, Kho ME, Browman GP, et al: Development of the AGREE II. 1. Performance, usefulness and areas for improvement. CMAJ 182: 1045-1052, 2010
70. Graham R, Mancher M, Miller Wolman DM, et al: (eds): Clinical Practice Guidelines We Can Trust. Washington, DC, National Academies Press, 2011
71. Atkins D, Best D, Briss PA, et al: Grading quality of evidence and strength of recommendations. BMJ 328:1490, 2004
72. Gibbons RJ, Smith SCJ, Antman E, et al: American College of Cardiology/American Heart Association clinical practice guidelines. II. Evolutionary changes in a continuous quality improvement project. Circulation 107:3101-3107, 2003
73. Mulder RL, Kremer LC, Hudson MM, et al: Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 14:e621-e629, 2013
74. Armenian SH, Hudson MM, Mulder RL, et al: Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 16: e123-e136, 2015
75. Hudson MM, Neglia JP, Woods WG, et al: Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. Pediatr Blood Cancer 58:334-343, 2012